BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6193340)

  • 1. Kinetic analysis of 5 alpha-reductase isoenzymes in benign prostatic hyperplasia (BPH).
    Rennie PS; Bruchovsky N; McLoughlin MG; Batzold FH; Dunstan-Adams EE
    J Steroid Biochem; 1983 Jul; 19(1A):169-73. PubMed ID: 6193340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5 alpha-reductase activity in cultured epithelial and stromal cells from normal and hyperplastic human prostates--effect of finasteride (Proscar), a 5 alpha-reductase inhibitor.
    Boudon C; Lobaccaro JM; Lumbroso S; Lechevallier E; Mottet N; Gibelin B; Sultan C
    Cell Mol Biol (Noisy-le-grand); 1995 Dec; 41(8):1007-15. PubMed ID: 8747081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic parameters of 5 alpha-reductase activity in stroma and epithelium of normal, hyperplastic, and carcinomatous human prostates.
    Bruchovsky N; Rennie PS; Batzold FH; Goldenberg SL; Fletcher T; McLoughlin MG
    J Clin Endocrinol Metab; 1988 Oct; 67(4):806-16. PubMed ID: 2458378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgens and estrogens: their interaction with stroma and epithelium of human benign prostatic hyperplasia and normal prostate.
    Krieg M; Bartsch W; Thomsen M; Voigt KD
    J Steroid Biochem; 1983 Jul; 19(1A):155-61. PubMed ID: 6193338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of aging on kinetic parameters of 5 alpha-reductase in epithelium and stroma of normal and hyperplastic human prostate.
    Tunn S; Hochstrate H; Grunwald I; Flüchter SH; Krieg M
    J Clin Endocrinol Metab; 1988 Nov; 67(5):979-85. PubMed ID: 2460487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Activity of 5 alpha-reductase in human hyperplastic prostates].
    Lin Y
    Zhonghua Yi Xue Za Zhi; 1991 May; 71(5):263-5, 20. PubMed ID: 1713809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Messenger RNA levels and enzyme activities of 5 alpha-reductase types 1 and 2 in human benign prostatic hyperplasia (BPH) tissue.
    Shirakawa T; Okada H; Acharya B; Zhang Z; Hinata N; Wada Y; Uji T; Kamidono S; Gotoh A
    Prostate; 2004 Jan; 58(1):33-40. PubMed ID: 14673950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of aging on kinetic parameters of 3 alpha(beta)-hydroxysteroid oxidoreductases in epithelium and stroma of human normal and hyperplastic prostate.
    Tunn S; Haumann R; Hey J; Flüchter SH; Krieg M
    J Clin Endocrinol Metab; 1990 Sep; 71(3):732-9. PubMed ID: 1697599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Androgen receptor and 5 alpha-reductase activity in the epithelium and the stroma of human benign prostatic hyperplasia].
    Oishi K; Okada K; Yoshida O; Romijn JC; Bolt de Vries J; Schröder FH
    Hinyokika Kiyo; 1985 May; 31(5):785-90. PubMed ID: 2413745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5alpha-reductase type 1 immunostaining is enhanced in some prostate cancers compared with benign prostatic hyperplasia epithelium.
    Thomas LN; Douglas RC; Vessey JP; Gupta R; Fontaine D; Norman RW; Thompson IM; Troyer DA; Rittmaster RS; Lazier CB
    J Urol; 2003 Nov; 170(5):2019-25. PubMed ID: 14532845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partial characterization of stromal and epithelial forms of 5 alpha-reductase in human prostate.
    Bruchovsky N; McLoughlin MG; Rennie PS; To MP
    Prog Clin Biol Res; 1981; 75A():161-75. PubMed ID: 6175974
    [No Abstract]   [Full Text] [Related]  

  • 12. Kinetic analysis of androstenedione 5 alpha-reductase in epithelium and stroma of human prostate.
    Weisser H; Krieg M
    Steroids; 1997; 62(8-9):589-94. PubMed ID: 9432753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selectivity of finasteride as an in vivo inhibitor of 5alpha-reductase isozyme enzymatic activity in the human prostate.
    Span PN; Völler MC; Smals AG; Sweep FG; Schalken JA; Feneley MR; Kirby RS
    J Urol; 1999 Jan; 161(1):332-7. PubMed ID: 10037433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of androgen metabolism in stroma and epithelium of the human benign prostatic hyperplasia by progesterone, estrone, and estradiol.
    Krieg M; Schlenker A; Voigt KD
    Prostate; 1985; 6(3):233-40. PubMed ID: 2581234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxytocin increases 5alpha-reductase activity of human prostate epithelial cells, but not stromal cells.
    Assinder SJ
    Prostate; 2008 Feb; 68(2):115-21. PubMed ID: 18008328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the sabal serrulata extract IDS 89 and its subfractions on 5 alpha-reductase activity in human benign prostatic hyperplasia.
    Weisser H; Tunn S; Behnke B; Krieg M
    Prostate; 1996 May; 28(5):300-6. PubMed ID: 8610056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stromal 5 alpha-reductase activity is elevated in benign prostatic hyperplasia.
    Wilkin RP; Bruchovsky N; Shnitka TK; Rennie PS; Comeau TL
    Acta Endocrinol (Copenh); 1980 Jun; 94(2):284-8. PubMed ID: 6158242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneity of 5 alpha-reductase gene expression in benign prostatic hyperplasia.
    Sherwood JB; McConnell JD; Vazquez DJ; Lin VK; Roehrborn CG
    J Urol; 2003 Feb; 169(2):575-9. PubMed ID: 12544310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression and significance of steroid 5alpha-reductase isoenzymes in benign hyperplastic prostate tissues].
    Ye LF; Zhang YF; Fang ZJ; Ding Q; Yao MS
    Zhonghua Yi Xue Za Zhi; 2003 Aug; 83(15):1296-9. PubMed ID: 12930680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of 5 alpha-reductase isoenzymes in the human prostate and prostatic carcinomas.
    Bonkhoff H; Stein U; Aumüller G; Remberger K
    Prostate; 1996 Oct; 29(4):261-7. PubMed ID: 8876709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.